On the other hand, MT-III found mainly in neurons seems to be involved in the control of amyloid plaque aggregation proteins or α-synuclein and neurofilaments, which may lead to the development of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. This evidence concerns the gene MT3 and early-onset autosomal dominant Alzheimer disease.